Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retinal Hyperspectral Imaging in Neurodegenerative Diseases

NCT07545473 is registered in ClinicalTrials.gov with Center for Eye Research Australia as lead sponsor.

NCT NCT07545473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07545473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retinal Hyperspectral Imaging in Neurodegenerative Diseases
Lead sponsor
Center for Eye Research Australia
Phase
Not applicable
Overall status
Recruiting
Start date
October 11, 2021
Completion date
December 31, 2028
Enrollment
930 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, dementia, frontotemporal dementia, lewy body disease, neurodegenerative diseases, niemann-pick diseases, parkinson disease, vascular dementia